TAK-070   Click here for help

GtoPdb Ligand ID: 6940

Compound class: Synthetic organic
Comment: TAK-070 from Takeda shows partial reduction in Aβ as well as increase in sAPPα in animal models. The noncompetitive BACE1 inhibition may be sufficient to modify amyloid pathology and ameliorate cognitive deficits in Alzheimer's Diseases without causing potential adverse events by complete BACE1 ablation.[1]
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 1
Hydrogen bond donors 0
Rotatable bonds 7
Topological polar surface area 12.47
Molecular weight 385.24
XLogP 6.92
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN(CCC1CCc2c(C1)ccc(c2)OCc1ccc(cc1)c1ccccc1)C
Isomeric SMILES CN(CC[C@@H]1CCc2c(C1)ccc(c2)OCc1ccc(cc1)c1ccccc1)C
InChI InChI=1S/C27H31NO/c1-28(2)17-16-21-8-13-26-19-27(15-14-25(26)18-21)29-20-22-9-11-24(12-10-22)23-6-4-3-5-7-23/h3-7,9-12,14-15,19,21H,8,13,16-18,20H2,1-2H3/t21-/m0/s1
InChI Key SETMAZMOXYOEJA-NRFANRHFSA-N
Bioactivity Comments
Lineweaver–Burk plot analysis indicated that TAK-070 inhibits BACE1 in a noncompetitive manner but at low potency. It did not inhibit cathepsin D, E, renin, γ-secretase nor activated of human TACE in cell-free assays.[1]
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
beta-secretase 1 Primary target of this compound Hs Inhibitor Non-competitive 4.7 pKi - 1
pKi 4.7 (Ki 1.9x10-5 M) [1]